Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected-Reference-Cited by-同舟云学术

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

Published:2011-12-08 Issue:12 Volume:6 Page:e27864
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gutiérrez Carolina,Díaz Laura,Vallejo Alejandro,Hernández-Novoa Beatriz,Abad María,Madrid Nadia,Dahl Viktor,Rubio Rafael,Moreno Ana M.,Dronda Fernando,Casado José Luis,Navas Enrique,Pérez-Elías María Jesús,Zamora Javier,Palmer Sarah,Muñoz Eduardo,Muñoz-Fernández María Ángeles,Moreno Santiago

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.;JK Wong;Science,1997

2. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.;S Palmer;Proc Natl Acad Sci U S A.,2008

3. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.;F Maldarelli;PLoS Pathog,2007

4. Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.;JA Anderson;J Virol.,2011

5. HIV rebounds from latently infected cells, rather than from continuing low-level replication.;B Joos;Proc Natl Acad Sci U S A,2008

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy;AIDS;2024-08-29

2. Eliminating the HIV tissue reservoir: current strategies and challenges;Infectious Diseases;2023-12-27

3. Frailty and Aging in HIV– Status Post 13 Years of National Awareness;The Journal of Frailty & Aging;2022

4. Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure;Frontiers in Immunology;2021-05-27

5. Effect of the Use of Galectin-9 and Blockade of the TIM-3 Receptor in the Latent Cellular Reservoir of HIV-1;Journal of Virology;2021-02-10